The news feels bittersweet. With 10+ of experience in healthcare AI, I have seen enough shitty products to genuinely welcome strict regulation for critical sectors; however, this shift threatens to dilute the sense of urgency that was growing in the sector.
We recently built a platform specifically to navigate the complex intersection of MDR (Medical Device Regulation) and the AI Act, relying on the pressure of hard deadlines. By introducing flexible timelines linked to technical standards, the EU risks signaling that compliance is a secondary concern, potentially stalling the momentum... and at this point patient safety is my biggest concern, not our platform
This introduces chaos rather than relief. Companies do not need lower standards; they need clarity.
We can compete effectively against high standards as long as the rules are clear. EU AI Act was clear. This proposal substitutes the certainty of a high bar with the confusion of a sliding scale, which may hinder the industry more than it helps :/
Macron’s focus should be on making sure that France’s existing AI successes like Mistral, Owkin, and Bioptimus have the right business environment for scaling and internationalizing, closing big initiatives with big corps/institutions rather than launching yet another public-sector initiative. These startups already demonstrate France’s AI potential, but they need strategic support to compete globally. Instead of reinventing the wheel with new government programs, why not double down on making these companies world leaders?
FondationDB is such an incredible resource, but it’s so hard to access for the general public. It’s no wonder so few people know about it. I’ve always thought that if there were easier ways to interact with it, or some dev-friendly layers built on top (or public) it would become way more popular. it has shown how well it scales with Apple and snowflake, but is not an obvious choice for non-internet scale applications.
If you don't know about FDB; there's an amazing video about how they test it that really got me into learning more:
Yeah, this is the bit for me. We have almost no good OSS layers for folks to "plug and play".
Its a bit of a vicious circle - because there is low exposure, no one is building those layers. Because no one is building the layers, there is no exposure.
All my kudos for the OrioleDB team, they have been working for years with the Postgres core devs to get the extensibility patches they need for their storage extensions merged back.
It’s not just about building their extension but actually making Postgres better for everyone. I would have loved that big corps would have taken this approach, as it opens the doors to others to add features for different use cases and making postgres more of a DBMS framework
> I would have loved that big corps would have taken this approach, as it opens the doors to others to add features for different use cases
EDB and Cybertech definitely made a great start with Zheap[0] although the initiative stalled for whatever reason
Hopefully the community can support this effort to improve the Table AM API - it would be beneficial even beyond oriole. As you point out, a Pluggable Storage system in Postgres would open up a few new use cases
i'm using a personal project , so far, it's been great. The code is easy to follow and the author AFAIK, he was working on an employer (Fly.io) that is giving him time and resources for litestream.
I would adventure to use it in a small production environment if you can have user/customer based sharding of sqlites and then have a clickhouse/postgres for multiuser analytics store.
IOMED | Data Engineer | Barcelona, Spain | Full Time | Onsite
Are you looking for a job with a direct impact on healthcare?
* Problem: Clinical data is messy and makes research slow.
* Mission: To structure clinical data and give unified, standardized access to it.
* Product: Natural language processing models and a unified SQL data access interface for researchers.
* Traction: Validated idea, Validated business model, growing and scaling stage.
* Funding: +2y runout and growing. Backed by national and international VCs.
* Stack: Python, Cython, SQL, Postgres, Kubernetes among others
* Values: Scientific, methodic, transparent, hard workers with a HUGE emphasis on work-life balance.
Join a multidisciplinary team working hard to make clinical research faster, accessible and ubiquitous. Also it's a nice excuse to enjoy Barcelona's vibe and nice weather !
Want to know more? Ping me at g@iomed.health or check our site for more info https://iomed.health/en
There is an Open Source (Go) implementation of "Zanzibar" called
Keto [0] that integrates with the rest of the Ory ecosystem. We are actually testing it and looks great so far.
This comes up every time but I think it’s worth noting that Keto provides literally none of the consistency properties of Zanzibar. All of the distributed systems homework assignments for that project have been left as TODOs.
Similar ideas are already patented [1]. I appreciate the simplicity of her approach, but I'm not sure if she would be able to create a business. I hope her the best.
> Although the above-referenced indicators are clas sified as solvatochromic, it should be understood that the present invention is not necessarily limited to any particular mechanism for the color change of the indicator. Even when a solvatochromic indicator is employed, other mechanisms may actually be wholly or partially responsible for the color change of the indicator. For example, acid-base or proton donation reactions between the indicator and microbe may result in the color change. As an example, highly organized acid moieties on bacteria cell walls may protonate certain indicators, resulting in a loss of color.
Patents are difficult to defend in that it has to specifically mention the new idea that you are trying to patent and not just refer to the general idea. However the statement above might be sufficiently close?
On the other hand, I just noticed its status as
"Abandoned."
Courts are very reticent to overturn a patent even if it is completely bogus. There are many of these bogus patents, the worst has to be a guy who patented "driving LEDs via their I2C interface" which is on par with patenting driving a car.
We recently built a platform specifically to navigate the complex intersection of MDR (Medical Device Regulation) and the AI Act, relying on the pressure of hard deadlines. By introducing flexible timelines linked to technical standards, the EU risks signaling that compliance is a secondary concern, potentially stalling the momentum... and at this point patient safety is my biggest concern, not our platform
This introduces chaos rather than relief. Companies do not need lower standards; they need clarity.
We can compete effectively against high standards as long as the rules are clear. EU AI Act was clear. This proposal substitutes the certainty of a high bar with the confusion of a sliding scale, which may hinder the industry more than it helps :/
reply